Clinical Trials Directory

Trials / Completed

CompletedNCT03940469

Dexmedetomidine Versus Dexamethasone With Levobupivacaine in Interscalene Block

Comparison Between Dexmedetomidine Versus Dexamethasone With Levobupivacaine in Ultrasound Guided Interscalene Block During Shoulder Arthroscopy: A Randomized Controlled Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Menoufia University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

The investigators compared between dexamethasone and dexmedetomidine when added to levobupivacaine in the quality and duration of ultrasound-guided interscalene block during shoulder arthroscopy.

Detailed description

Sixty patients were enrolled and divided into three groups 20 each, Group C received 35ml levobupivacaine+2ml normal saline under ultrasound guided interscalene block. Group H received 35ml levobupivacaine+8mg dexamethasone under ultrasound guided interscalene block. Group D received 35ml levobupivacaine+100umg dexmedetomidine+1ml normal saline. The primary outcome was the postoperative pain which was assessed by Visual analog score(VAS), the secondary outcomes were the onset and duration of sensory and motor block, the total amount of analgesic requirement, and blood cortisol level.

Conditions

Interventions

TypeNameDescription
DRUGSaline2 ml normal saline
DRUGDexamethasone Injection8 mg dexamethasone
DRUGDexmedetomidine Hydrochloride100 microgram dexmedetomidine

Timeline

Start date
2016-07-03
Primary completion
2019-01-01
Completion
2019-01-01
First posted
2019-05-07
Last updated
2019-05-07

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03940469. Inclusion in this directory is not an endorsement.